APP下载

哇巴因对肝癌细胞株P-gp表达的影响研究

2019-09-28杨明镇赵逵

中国实用医药 2019年24期

杨明镇 赵逵

【摘要】 目的 研究哇巴因对肝癌细胞株P-糖蛋白(P-gp)表达的影响。方法 选用人肝癌Bel-7402细胞株, 阿霉素(ADM)大剂量间断冲击法建立Bel-7402/ADM模型并设为耐药组, 正常Bel-7402设为对照组。采用免疫印迹(WB)检测两组哇巴因干预前后P-gp表达水平。结果 哇巴因干预前, 耐药组P-gp表达水平为(72.68±0.07), 对照组为(22.21±0.04);哇巴因干预后, 耐药组P-gp表达水平为(20.61±0.04), 对照组为(14.32±0.05);哇巴因干预后, 两组P-gp水平均显著低于哇巴因干预前, 差异有统计学意义(P<0.05);哇巴因干预前后耐药组P-gp水平均显著高于对照组, 差异有统计学意义(P<0.05)。结论 哇巴因可有效下调肝癌细胞株P-gp的表达。

【关键词】 哇巴因;肝癌细胞株;P-糖蛋白

DOI:10.14163/j.cnki.11-5547/r.2019.24.107

Effect of ouabain on the expression of P-gp in hepatocellular carcinoma cell line   YANG Ming-zhen, ZHAO Kui. Department of Invasive Technology, Affiliated Hospital of Zunyi Medical College, Zunyi 563003, China

【Abstract】 Objective   To study the effect of ouabain on the expression of P-glycoprotein (P-gp) in hepatocellular carcinoma cell line. Methods   The Bel-7402/ADM model of human hepatocellular carcinoma cell line Bel-7402 was established by high-dose intermittent impulse method with adriamycin (ADM) as drug-resistant group and normal Bel-7402 as control group. The expression of P-gp was detected by Western blotting (WB) before and after ouabain intervention in the two groups. Results   Before intervention of ouabain, drug-resistant group had P-gp expression level as (72.68±0.07), which was (22.21±0.04) in the control group. After intervention of ouabain, drug-resistant group had P-gp expression level as (20.61±0.04), which was (14.32±0.05) in the control group. After intervention of ouabain, both groups had significantly lower P-gp expression level than those before intervetion of ouabain, and the difference was statistically significant (P<0.05). Before and after intervention of ouabain, drug-resistant group had significantly higher P-gp expression level than the control group, and the difference was statistically significant (P<0.05). Conclusion   Ouabain can effectively down-regulate the expression of P-gp in hepatocellular carcinoma cell line.

【Key words】 Ouabain; Hepatocellular carcinoma cell line; P-glycoprotein

肝癌(liver  cancer)是指發生于肝脏或从肝脏开始的恶性肿瘤, 使机体基因转录异常, 细胞失去正常增殖、分化、凋亡能力[1]。肝癌发病隐蔽, 初期无明显症状, 病情进展迅速, 临床症状多表现为发热、乏力、纳差、消瘦、消化道症状及最常见的肝区疼痛, 多因癌细胞迅速生长致肝包膜紧绷导致, 疼痛可辐射至右肩[2]。体征常见肝脾肿大、腹水黄疸等。肝癌确诊时患者往往已到晚期或已发生转移, 大多数患者无法通过手术根治, 预后差, 复发率高。化疗是目前最主要治疗手段[3], 长时间使用化疗药物易导致肿瘤多药耐药性(multidrug resistance, MDR)[4], 影响药物吸收, 制约疗效, 危害患者身心健康。研究表明, P-糖蛋白(P-glycoprotein, P-gp)是MDR基因编码的一种跨膜转运蛋白, 参与机体解毒及代谢, 可将细胞内毒性代谢产物外排出细胞, 保护细胞受损。临床上对哇巴因干预下P-gp表达影响研究较少, 因此本文旨在探讨哇巴因对肝癌细胞株P-gp表达的影响, 期望为临床治疗提供实验和理论依据, 现将研究结果报告如下。……

登录APP查看全文